Clinical Trials Browser

Interventional × Pancreatic Neoplasms × Pioglitazone × Clear all

NCT01838317 2021-03-01

A Phase II Study of Pioglitazone for Patients With Cancer of the Pancreas

Phase 2 Completed

14 enrolled 8 charts

Gastrointestinal

Pancreatic Neoplasms

NCT00867126 2018-11-26

Pioglitazone as Second-Line in Patients With Metastatic Pancreatic Cancer After Treatment With Gemcitabine

Phase EARLY_PHASE1 Terminated

Gastrointestinal

Pancreatic Neoplasms